Literature DB >> 26606907

Down-regulation of 5S rRNA by miR-150 and miR-383 enhances c-Myc-rpL11 interaction and inhibits proliferation of esophageal squamous carcinoma cells.

Xinyu Wang1, Yanli Ren2, Zhiqiong Wang2, Xiangyu Xiong2, Sichong Han2, Wenting Pan2, Hongwei Chen2, Liqing Zhou3, Changchun Zhou4, Qipeng Yuan2, Ming Yang5.   

Abstract

5S rRNA plays an important part in ribosome biology and is over-expression in multiple cancers. In this study, we found that 5S rRNA is a direct target of miR-150 and miR-383 in esophageal squamous cell carcinoma (ESCC). Overexpression of miR-150 and miR-383 inhibited ESCC cell proliferation in vitro and in vivo. Moreover, 5S rRNA silencing by miR-150 and miR-383 might intensify rpL11-c-Myc interaction, which attenuated role of c-Myc as an oncogenic transcriptional factor and dysregulation of multiple c-Myc target genes. Taken together, our results highlight the involvement of miRNAs in ribosomal regulation during tumorigenesis.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5S rRNA; Esophageal squamous cell carcinoma; c-Myc; miR-150; miR-383

Mesh:

Substances:

Year:  2015        PMID: 26606907     DOI: 10.1016/j.febslet.2015.11.012

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma.

Authors:  Li Chen; Yulin Jin; Lin Wang; Fenghao Sun; Xiaodong Yang; Mengkun Shi; Cheng Zhan; Yu Shi; Qun Wang
Journal:  Med Oncol       Date:  2016-11-26       Impact factor: 3.064

2.  Mice Expressing Myc in Neural Precursors Develop Choroid Plexus and Ciliary Body Tumors.

Authors:  Morgan L Shannon; Ryann M Fame; Kevin F Chau; Neil Dani; Monica L Calicchio; Gwenaelle S Géléoc; Hart G W Lidov; Sanda Alexandrescu; Maria K Lehtinen
Journal:  Am J Pathol       Date:  2018-03-13       Impact factor: 4.307

3.  Circ_0005231 promotes the progression of esophageal squamous cell carcinoma via sponging miR-383-5p and regulating KIAA0101.

Authors:  Zhiguang Sun; Shaowei Zhang; Nan Zhang; Jianxin Wang; Jindong Wang; Junfeng Liu
Journal:  Thorac Cancer       Date:  2022-05-06       Impact factor: 3.223

4.  Identifying reproducible cancer-associated highly expressed genes with important functional significances using multiple datasets.

Authors:  Haiyan Huang; Xiangyu Li; You Guo; Yuncong Zhang; Xusheng Deng; Lufei Chen; Jiahui Zhang; Zheng Guo; Lu Ao
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

5.  The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer.

Authors:  Zhixiong Fang; Langqiu He; Hui Jia; Qiusheng Huang; Dan Chen; Zhiwei Zhang
Journal:  Iran J Basic Med Sci       Date:  2017-02       Impact factor: 2.699

6.  Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma.

Authors:  Wen-Tao Wang; Ziqiang Li; Meng Shi; Hui Zhu; Xiangyu Xiong; Jinhua Shang; Jibing Liu; Mujian Teng; Ming Yang
Journal:  Oncotarget       Date:  2016-08-30

7.  Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas.

Authors:  Peeter Karihtala; Katja Porvari; Ylermi Soini; Kirsi-Maria Haapasaari
Journal:  Oxid Med Cell Longev       Date:  2017-03-09       Impact factor: 6.543

Review 8.  Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress.

Authors:  Annapina Russo; Giulia Russo
Journal:  Int J Mol Sci       Date:  2017-01-12       Impact factor: 5.923

9.  MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.

Authors:  Dongfang Bai; Haipeng Sun; Xiaodong Wang; Hongliang Lou; Jian Zhang; Xiaohong Wang; Ling Jiang
Journal:  Med Sci Monit       Date:  2017-10-12

10.  Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.

Authors:  Lei Wang; Ailixiati Aireti; Aizezi Aihaiti; Kun Li
Journal:  Pathol Oncol Res       Date:  2018-09-15       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.